ALYSSA WYLLIE: Open Payments
NPI 1023725454 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 43 payments from 19 companies in 2025. Trend: 2023 $1,901 · 2024 $1,938 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $156 |
| AstraZeneca Pharmaceuticals LP | 5 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Antares Pharma, Inc. | 4 | $87 |
| Verity Pharmaceuticals Inc. | 2 | $50 |
| PFIZER INC. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $30 |
| Lundbeck LLC | 1 | $28 |
| Dexcom, Inc. | 1 | $26 |
Products named: JARDIANCE, XYOSTED, BREZTRI, AIRSUPRA, Ozempic, Wegovy, Tlando, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
